Polyclone Bio Services Private Limited - Due diligence report

A 360° intelligence report on Polyclone Bio Services Private Limited: trust score, financial health, credit view, compliance, directors, gro…

2003-12-26 Bangalore, Karnataka Active Unlisted Active Non-Compliant
Share
Connect MCP
PB Polyclone Bio Services Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Polyclone Bio Services Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
53/100
Trust Score
Moderate

Polyclone Bio Services Private Limited is assessed as Moderate with a Trust Score of 53/100. Polyclone Bio Services Private Limited is an active private limited indian non-government company incorporated in 2003, operating in the Research & Development sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 17 Aug 2026 from the latest processed filings. Polyclone Bio Services Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
53/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
55/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 1 open (25.00 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India1 48.0 cr
Compliance Score: 55/100 Moderate
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2017 - filings overdue.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
NAVEEN KULKARNI 01234567 Director 01/04/2018 6 yrs Approved
RAJENDRA PRAVEEN 01234567 Director 01/04/2018 6 yrs Approved
SANJAY BETTADPURA SHRIPATHY 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • SANJAY BETTADPURA SHRIPATHY has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2016)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Key managerial personnel: NAVEEN KULKARNI (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 80
Growth signals & trust indicators
Operating for 22+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Compliance score is weak (55/100).
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment35/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 25.00 Lakh already registered.
  • Compliance gaps should be priced into terms.
Investor view17/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2017
Last AGM held
Annual general meeting
31 Mar 2017
Latest balance sheet
Filed with ROC
11 Oct 2016
Director ceased
NAVEEN KULKARNI
12 Mar 2010
Securities allotted
3754.00 Equity Shares - 15.02 Lakh raised
22 Dec 2009
Securities allotted
50000.00 Equity Shares - 50.00 Lakh raised
12 Feb 2008
Securities allotted
994.00 Equity Shares - 23.81 Lakh raised
05 Mar 2007
Securities allotted
160000.00 Equity Shares - 21.88 Lakh raised
26 Apr 2006
Charge created
State Bank Of India - 25.00 Lakh
08 Apr 2005
Director appointed
RAJENDRA PRAVEEN (Director)
26 Dec 2003
Incorporated
Registered with Roc Bangalore
Director appointed
NAVEEN KULKARNI (Managing Director)
Director appointed
SANJAY BETTADPURA SHRIPATHY (Director)
10

Key Observations

Auto-generated from the data above
3 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold the largest single block of equity as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Rf Trans Consultant And Services Private Limited (Opc) U93030UP2014OPC066956 Noida, Uttar Pradesh, India
Adelika Research And Agricultural Institute U73100MP2012NPL029614 Chhatarpur, Madhya Pradesh, India
Classic Enviro Care Tamilnadu Private Limited U74999TZ2007PTC014063 Coimbatore, Tamil Nadu, India
Inclusive Energy (India) Private Limited U52500OR2016PTC025396 Bhubaneswar, Orissa, India
Opaan Technologies Private Limited U72900UP2014PTC063589 Greater Noida, Uttar Pradesh, India
Pentagram Research Centre Private Limited U73100TG1997PTC026505 Hyderabad, Telangana, India
Brookings Institution India Private Limited U74140DL2012FTC246562 New Delhi, Delhi, India
Vaibhav Research Center And Care Private Limited U74999BR2016PTC031497 Phulwari, Bihar, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Polyclone Bio Services Private Limited before audits and certifications: compliance score 55/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Polyclone Bio Services Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Polyclone Bio Services Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 53/100, distress signals and MSME payment-delay disclosures - know whether Polyclone Bio Services Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Polyclone Bio Services Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Polyclone Bio Services Private Limited an active company?

Polyclone Bio Services Private Limited has MCA status “Active” with a compliance score of 55/100 (Moderate).

Is Polyclone Bio Services Private Limited financially healthy?

Polyclone Bio Services Private Limited has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Polyclone Bio Services Private Limited?

Its overall Trust Score is 53/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Polyclone Bio Services Private Limited?

Promoters hold the largest single block of equity - exact percentages are in the full report. 3 active director(s) are on record.

Does Polyclone Bio Services Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Polyclone Bio Services Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 55/100 (Moderate).

Is it risky to lend to Polyclone Bio Services Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.